HOME



Investments
Novogen stock trades on both the Australian Stock Exchange and the NASDAQ exchange in the USA.

Current prices:
ASX (NRT)
NASDAQ (NVGN)

 

Back Shares

At 30 June 2008, there were:

97,594,261 ordinary shares outstanding and

4,387 individual shareholders on the Australian Share Register.


  Top

 





About Novogen | Knowledge Base | Consumer Health | Pharmaceuticals | News | Investor Relations | Contact | Site Map
Copyright © 2010 Novogen The world leader in isoflavone research - with products including Promensil and Trinovin | Web Design by Newgency